期刊
JOURNAL OF DRUG TARGETING
卷 21, 期 1, 页码 67-76出版社
TAYLOR & FRANCIS LTD
DOI: 10.3109/1061186X.2012.729213
关键词
Carbon nanotubes; dexamethasone mesylate; functionalization; doxorubicin
资金
- University Grant Commission (UGC), New Delhi, India
Dexamethasone conjugated multi wall carbon nanotubes (DEX-MWCNTs) were developed for controlled delivery of a doxorubicin HCl (DOX) with reduced toxicity. The DEX-MWCNTs were prepared by sequential functionalization of MWCNTs. The DOX was physically loaded onto the purified raw MWCNTs and DEX-MWCNTs at pH 7.4 phosphate buffer solutions (PBS) and evaluated for entrapment efficiency, in vitro release, hemolytic toxicity and ex vivo studies on A-549 lung epithelial cancer cell line. DOX was efficiently loaded into purified raw and DEX-MWCNTs formulation and the highest entrapment of DOX was found to be 92.6 +/- 0.5% in the case of DEX-MWCNTS with good dispersion. In-vitro release of DOX was studied from the DOX/DEX-MWCNTs at pH 5.5 and 7.4 (PBS), which displayed an initial faster followed by sustained release up to 200 h. Further, DOX/DEX-MWCNTs were found to be less hemolytic and more cytotoxic as compared to free DOX on A-549 lung epithelial cancer cell line.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据